Archives
Keywords
Press
-
Renowned leader in the anti-infective drug industry invests in ANTABIO
01/12/2012ANTABIO welcomes M. Christophe RICARD former CEO of the Swiss pharmaceutical group OM Pharma as its new investor
» Read more
-
Fight against drug-resistant bacteria: Antabio highlighted in the News
12/5/2011Antabio is being recognized as a key player in the fight against drug-resistant bacteria. Antabio appears in the last issues of 2 magazines.
» Read more
-
Antabio will attend the French Biotech Tour in Boston
09/8/2011Antabio will attend the French Biotech Tour in Boston from the 20 to 21 september 2011 What is the French Biotech Tour?
» Read more
-
Fight against E.coli: Antabio highlighted in the News
07/11/2011
» Read more
-
Antabio obtains financial support from Oséo
07/4/2011 » Read more
-
ANTABIO is attending the 12th National Meeting on Infectiology in Toulouse
06/9/2011The JNI is a place for sharing experiences, exchange, updating our knowledge and practices, but also reflection on our current and future performance.
» Read more
-
L’épidémie mortelle causée par la bactérie Escherichia coli O104:H4 nécessite une réponse rapide et concertée
06/3/2011 » Read more
-
WHO day 2011 on Antibiotic resistance: Read the Statement by WHO Director-General, Dr Margaret Chan
04/7/2011When the first antibiotics were introduced in the 1940s, they were hailed as “wonder drugs”, the miracles of modern medicine. And rightly so. Widespread infections that killed many millions of people every year could now be cured.
» Read more
-
An Equity Security Priming Loan granted to ANTABIO by OSEO
03/4/2011ANTABIO announces that an Equity Security Priming Loan (“Prêt participatif à l’amorçage”) has been granted to Antabio by Oseo, the French Public Establisment responsible for supporting innovation and growth of SMEs in France.
» Read more
-
ANTABIO announces the completion of the first round of its 1 million euro seed financing
02/14/2011The raising of 309K€ was conducted in partnership with WISEED, a crowd funding internet platform. ” This transaction, which involved the constitution of a holding of shareholders in less than two months, is one of the most successful deals carried out by Wiseed date” says enthusiastically Thierry Merquio, CEO of Wiseed.
» Read more